VA disability ratings to ignore medication benefits—veterans may lose compensation

What it does

This bill amends the VA's disability rating schedule to require that ratings be based on a veteran's condition WITHOUT the benefit of medication or treatment, establishing a baseline disability level. However, veterans can still claim additional compensation if the medication or treatment itself causes new disabilities or worsens existing ones. The practical effect is that a veteran whose condition is well-controlled by medication will receive a disability rating reflecting their underlying condition, not their medicated state.

Why we flagged it

The bill is a technical amendment to the statutory framework governing how the VA calculates disability ratings. It does not create new benefits or cut them outright; it changes the baseline against which ratings are measured — from current functional state (with medication) to underlying condition (without medication). This is a methodological shift with real distributional consequences.

What the text implies

• Veterans whose conditions are well-managed by medication may experience rating reductions and corresponding compensation cuts, even if their underlying disability severity has not changed. The bill does not grandfather existing ratings, so implementation could affect current beneficiaries.
• The bill creates a two-tier claim process: one for the baseline disability (without medication effects) and a separate claim for medication/treatment-caused harms. Veterans must navigate both to recover full compensation, increasing administrative burden and litigation risk.
• The phrase 'when evidence can be used to establish a baseline without those beneficial effects' is undefined in the bill itself. VA will have discretion to determine what evidence is sufficient, potentially creating inconsistent application across regional offices.
• The bill does not address how to rate conditions for which medication is the only evidence of severity (e.g., a veteran whose condition is invisible without treatment). The 'baseline without beneficial effects' standard may be impossible to apply in such cases.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Veterans with well-controlled conditions via medication may see lower disability ratings and reduced compensation, a concrete cost. However, the bill explicitly preserves the right to claim separate compensation for medication side effects or treatment-caused aggravation, and it clarifies the rating methodology in statute rather than leaving it to VA discretion, which is a transparency gain. The balance depends on how VA implements the baseline-discount rule and whether veterans successfully nav

Named in the bill

Department of Veterans Affairs, VA, 38 USC § 1155, Carlton H. Ingram

Where it stands

7 cosponsors: 5 Democrats, 2 Independents.

• Mar 19, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Mar 19, 2026 — Referred to Senate Committee on Veterans' Affairs · Congress.gov: “Read twice and referred to the Committee on Veterans' Affairs”
• Apr 29, 2026 — Hearing held · Congress.gov: “Committee on Veterans' Affairs. Hearings held”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.